Fig. 3. Decreased amounts of MIRTD mRNA in brains of patients with AD. Amounts of MIRTD mRNA in the brains of AD patients or controls were measured by real-time quantitative RT–PCR and normalized against those of (A) DLST or (B) GAPDH mRNA as described in Materials and methods. Numbers of samples, mean values with standard deviations (± SD) and p values as judged by Student’s t-test are given in the figure.